Curaleaf Holdings Inc

Most Recent

  • uploads///Marijuana
    Cannabis

    Marijuana Legalization: More Americans Are Saying Yes

    Marijuana legalization is gathering steam as one of the key topics for the 2020 presidential election. Marijuana is still a federally controlled substance.

    By Sirisha Bhogaraju
  • uploads///canopy
    Consumer

    Canopy Growth Stock Rises, Oppenheimer Initiates Coverage

    Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.

    By Sushree Mohanty
  • uploads///A Photo Representing a Bill With a Pen
    Cannabis

    Marijuana Legalization: House Passes SAFE Act in US

    Yesterday, the House passed the Secure and Fair Enforcement Banking Act, which aims to reduce cash transactions for legitimate marijuana businesses.

    By Adam Jones
  • uploads///canopy growth cannabis
    Cannabis

    Canopy Growth: New Cannabis 2.0 Products amid COVID-19

    Canopy Growth (NYSE:CGC)(TSE:WEED) still has investors’ attention despite all that the marijuana industry has gone through.

    By Sushree Mohanty
  • uploads///
    Cannabis

    Medical Marijuana Is Booming in OK, Struggles in OH

    Medical marijuana is a hit in Ohio since it allowed it in 2016. Recreational cannabis is still not allowed. Notably, data has shown that Ohio’s medical cannabis industry is booming since it started in 2019. However, the medical cannabis industry is facing some setbacks as well. So, let’s take a look at it. Ohio and […]

    By Sushree Mohanty
  • uploads///california marijuana future
    Cannabis

    Marijuana Industry: Opportunities in California amid COVID-19

    Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis Sector 2019 Review and 2020 Outlook

    Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: Will Trump Have an Edge over Biden?

    With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray: Are Analysts Optimistic about Its Stock?

    After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: Why Is Washington Changing Its Laws?

    In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.

    By Sushree Mohanty
  • Cannabis

    Cannabis 2.0 Legalization: Canada Is Ready

    Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]

    By Sushree Mohanty
  • uploads///Opioid
    Cannabis

    Opioid Crisis: Is Cannabis Legalization a Good Idea?

    According to the CDC, about 400,000 people died from opioid overdoses from 1999 to 2017. The number includes deaths from prescription and illegal opioids.

    By Sirisha Bhogaraju
  • uploads///acreage holdings q results
    Cannabis

    Acreage Holdings Posts Disappointing Results in Q1 2020

    Acreage Holdings’ first-quarter pro forma revenue grew 65% YoY (year-over-year) to $37.6 million. The revenue beat analysts’ estimates of $34.9 million.

    By Sushree Mohanty
  • uploads///marijuana covid
    Cannabis

    Could Certain Marijuana Strains Help Fight COVID-19?

    The cannabis industry is doing its own research amid COVID-19. Researchers discovered that marijuana might have properties to fight the coronavirus.

    By Sushree Mohanty
  • uploads///herb _
    Company & Industry Overviews

    Curaleaf Opens Medical Marijuana Dispensary in Tallahassee

    On November 16, Curaleaf Holdings announced that the company opened Tallahassee’s largest medical marijuana dispensary.

    By Mike Benson
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What’s the Word on the Street?

    Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.

    By Sushree Mohanty
  • uploads///republicans democrats marijuana
    Cannabis

    Marijuana Legalization: Democrats and Republicans’ Opposing Views

    Democrats and Republicans have always had opposing views about marijuana legalization. Republicans could gain voters if they support legalization.

    By Sushree Mohanty
  • uploads///PLTH_
    Company & Industry Overviews

    Planet 13 Inks Deal with Mike Tyson’s Cannabis Venture

    Today, Planet 13 Holdings (PNTH) (PLNHF) announced that it had inked a purchase agreement with Tyson Ranch, which is owned by boxer Mike Tyson.

    By Rajiv Nanjapla
  • uploads///can
    Cannabis

    Cannabis Investing in 2019: A Year of Big Reversals

    The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

    By Rajiv Nanjapla
  • uploads///Cannabis
    Cannabis

    Cannabis Legalization: Dark Clouds Loom Post Debate

    Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

    By Sushree Mohanty
  • uploads///Acreage
    Cannabis

    Acreage: Analysts Lower Targets after Q3 Earnings

    Acreage Holdings (ACRG)(ACRGF) reported its third-quarter earnings after markets closed on November 12. Here’s how analysts have reacted since.

    By Rajiv Nanjapla
  • uploads///p
    Cannabis

    Curaleaf Stock: Latest Updates for Investors

    Lately, Curaleaf (CURLF) stock received some attention from cannabis investors. The company announced the acquisition of GR Companies on July 17. The acquisition would make Curaleaf one of the biggest cannabis companies. To learn more, read Curaleaf Will Soon Be the World’s Largest Cannabis Company. After the announcement, Curaleaf stock closed almost 17% higher at […]

    By Market Realist
  • uploads///AISC
    Cannabis

    Marijuana Legalization: ‘Make It Legal Florida!’

    Marijuana legalization is firing up. Currently, cannabis is legal for recreational use in ten states and Washington DC. Cannabis is legal for medical use in 33 states. Other states are also gearing up to legalize marijuana. Today, we’ll discuss how Florida is stepping up for cannabis legalization. “Make it legal, Florida!” Legalizing medical marijuana has […]

    By Adam Jones
  • uploads///cresco labs ohio
    Cannabis

    Cresco Labs Announces Expansion in Ohio before Q1 Earnings

    Cresco Labs (OTCMKTS:CRLBF) will likely report its financial results for the first quarter of fiscal 2020 on May 28 after the market closes.

    By Sushree Mohanty
  • uploads///marijuana montana
    Cannabis

    Marijuana Legalization Proceeds in Montana amid COVID-19

    New Approach Montana resumed its marijuana legalization campaign in May. The group submitted plenty of signatures and qualified for the November ballot.

    By Sushree Mohanty
  • uploads///kushco earnings
    Cannabis

    What to Expect from KushCo Holdings’ Q3 Earnings

    KushCo Holdings will likely report its third-quarter results on Wednesday. The company will have an earnings call before the market opens.

    By Sushree Mohanty
  • uploads///curaleaf new jersey
    Cannabis

    Curaleaf Holdings Completes Curaleaf NJ’s Acquisition

    Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

    By Rajiv Nanjapla
  • uploads///organigram delay
    Cannabis

    OrganiGram Lays Off 220 Employees, Delays Q3 Earnings

    To survive amid the current COVID-19 crisis, OrganiGram (NASDAQ:OGI) announced restructuring changes including a 25% cut in its workforce.

    By Sushree Mohanty
  • uploads///kushco struggles
    Cannabis

    KushCo Holdings Reported Lower Q3 Results, Stock Rose 10%

    KushCo Holdings’ third-quarter net revenue was $22.3 million, which was much lower than analysts’ estimate of $31.1 million.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization Still Has a Chance in Idaho

    Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.

    By Sushree Mohanty
  • uploads///curaleaf
    Cannabis

    Is Curaleaf a Good Cannabis Pick in 2020?

    Curaleaf (OTCMKTS:CURLF) is one of the vertically integrated US cannabis companies. The company has been a top player in the US cannabis space.

    By Sushree Mohanty
  • uploads///Organigram
    Cannabis

    Haywood Capital Markets Reduced OrganiGram’s Target Price

    OrganiGram (NASDAQ:OGI) stock is trading higher before its third-quarter earnings. The stock closed with a gain of 3.9% at $1.58 on Wednesday.

    By Sushree Mohanty
  • uploads///curaleaf q earnings
    Cannabis

    Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand

    Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.

    By Rajiv Nanjapla
  • uploads///green thumb store
    Cannabis

    Green Thumb Keeps Expanding Its Operations in Las Vegas

    On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.

    By Rajiv Nanjapla
  • uploads///canopy growth acreage holdings deal
    Cannabis

    Canopy Growth Revised Its Agreement with Acreage Holdings

    Canopy Growth entered into an agreement with US-based cannabis company Acreage Holdings last year. However, the company announced some changes.

    By Sushree Mohanty
  • uploads///acreage holdings upcoming results
    Cannabis

    Could Acreage Holdings’ Q1 Earnings Boost Its Stock?

    Acreage Holdings (OTCMKTS:ACRGF) will likely report its results for the first quarter of fiscal 2020 on Friday before the market opens.

    By Sushree Mohanty
  • uploads///medmen relief
    Cannabis

    MedMen’s Medical Marijuana Dispensary License Revoked in Virginia

    The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.

    By Rajiv Nanjapla
  • uploads///virgin islands marijuana legalization
    Cannabis

    U.S. Virgin Islands’ Governor Supports Marijuana Legalization

    While most businesses suffered amid COVID-19, marijuana saw a drastic rise in sales. Many states have been rethinking the benefits of marijuana legalization.

    By Sushree Mohanty
  • uploads///charlottes web abacus health
    Cannabis

    Will the Abacus Health Acquisition Benefit Charlotte’s Web?

    On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.

    By Sushree Mohanty
  • uploads///Curaleaf
    Cannabis

    Curaleaf Expands Select Brand Medical Products in Connecticut

    On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.

    By Rajiv Nanjapla
  • uploads///iipr earnings
    Cannabis

    IIPR Acquires Another Property in Pennsylvania

    Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.

    By Rajiv Nanjapla
  • uploads///green thumb industries
    Cannabis

    Green Thumb Industries Opens Its 46th Retail Store

    On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.

    By Rajiv Nanjapla
  • uploads///arkansas marijuana
    Cannabis

    Marijuana Legalization Campaign in Arkansas Gets a Boost

    US states have been looking at strategies to gather signatures and qualify for the 2020 ballot. The pandemic made gathering signatures a challenge.

    By Sushree Mohanty
  • uploads///marijuana new mexico primaries
    Cannabis

    Marijuana Legalization: New Mexico Voters Show Support

    In the 2020 New Mexico Democratic presidential primaries election on June 2, voters ousted most of the Senate candidates who opposed marijuana legalization.

    By Sushree Mohanty
  • uploads///bermuda cannabis market
    Cannabis

    Bermuda Seeks Public Feedback on Legal Cannabis Market

    Bermuda wants to expand its legal cannabis market. The government wants public feedback before the upcoming Bermuda Parliament sessions.

    By Sushree Mohanty
  • uploads///cresco labs ohio approval
    Cannabis

    Cresco Labs Receives Ohio Provisional Processing License

    Cresco Labs (OTCMKTS:CRLBF) is trading 1.8% higher as of 9:44 AM ET today. The company received a provisional processing license by the state of Ohio.

    By Sushree Mohanty
  • uploads///new york marijuana again
    Cannabis

    Marijuana Legalization Attempts in New York amid Protests

    George Floyd’s death has led to mass protests in the US. Notably, social injustice was one of the main motives behind legalizing marijuana.

    By Sushree Mohanty
  • uploads///cresco labs estimates
    Cannabis

    Cresco Labs: Analysts Revise 2020 Estimates after Earnings

    Cresco Labs (OTCMKTS:CRLBF) is one of the US cannabis companies that has been consistently performing well despite the marijuana industry’s struggles.

    By Sushree Mohanty
  • uploads///medmen stores closed
    Cannabis

    MedMen Temporarily Closes Stores amid Protests

    Amid the protests following George Floyd’s death in the US, MedMen temporarily closed all of its stores. The stock fell after the news.

    By Sushree Mohanty
  • uploads///green thumb industries good bet
    Cannabis

    Why Green Thumb Industries Is a Good Cannabis Bet

    So far in 2020, Green Thumb Industries has returned 6.0%—one of the few cannabis companies with positive returns this year.

    By Rajiv Nanjapla
  • uploads///medmen relief
    Cannabis

    Will MedMen’s Q3 2020 Earnings Be a Relief?

    MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.

    By Sushree Mohanty
  • uploads///Curaleaf
    Cannabis

    Curaleaf: Analysts’ Recommendations after Its Q1 Earnings

    Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.

    By Rajiv Nanjapla
  • uploads///curaleaf q earnings
    Cannabis

    Why Did Curaleaf Report a Mixed Q1 Performance?

    On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.

    By Rajiv Nanjapla
  • uploads///green thumb industries
    Cannabis

    Green Thumb Industries Had a Good Start to Fiscal 2020

    Green Thumb Industries reported impressive results for the first quarter of fiscal 2020 on Thursday after the market closed.

    By Sushree Mohanty
  • uploads///texas marijuana
    Cannabis

    Could Marijuana Legalization Help Texas Recover Its Losses?

    Texas has suffered huge economic losses. Many industry experts think that marijuana legalization could be a good option to revive the state’s economy.

    By Sushree Mohanty
  • uploads///cweb_
    Cannabis

    Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings

    Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Charlotte’s Web Reports Mixed Q1 Performance

    Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.

    By Rajiv Nanjapla
  • uploads///charlottes web upcoming earnings
    Cannabis

    Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings

    Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.

    By Rajiv Nanjapla
  • uploads///iipr earnings
    Cannabis

    IIPR Stock Falls after Reporting Weak Q1 Performance

    On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.

    By Rajiv Nanjapla
  • uploads///CRON_
    Cannabis

    Should You Buy IIPR before Its Q1 Earnings?

    IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?

    By Rajiv Nanjapla
  • uploads///marijuana
    Cannabis

    Marijuana Legalization Sees Daylight in Lebanon, US Still Waits

    Amid COVID-19, people rushed to stock up on marijuana. Lebanon is the first Middle East country to legalize medical marijuana amid the pandemic.

    By Sushree Mohanty
  • uploads///cresco labs surprise results
    Cannabis

    Cresco Labs’ Q4 Earnings: Pleasant Surprise amid COVID-19

    Cresco Labs reported its results for the fourth quarter of fiscal 2019 on April 27. Analysts were hopeful about the company’s fourth-quarter earnings.

    By Sushree Mohanty
  • uploads///Marijuana
    Cannabis

    Why Is There Optimism before Cresco Labs’ Q4 Earnings?

    Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.

    By Rajiv Nanjapla
  • uploads///cronos group earnings expectations
    Cannabis

    What to Expect from Cronos Group’s Q4 Earnings Today

    Cronos Group will report its fourth-quarter and fiscal 2019 results after the market closes today—a delay from the original date of February 27.

    By Sushree Mohanty
  • uploads///CWEB_
    Cannabis

    Analysts’ Recommendations after Charlotte’s Web’s Q4 Earnings

    Charlotte’s Web Holdings reported its fourth-quarter earnings on March 24. For the quarter, the company missed analysts’ revenue and EBITDA estimates.

    By Rajiv Nanjapla
  • uploads///curaleaf target price
    Cannabis

    Analysts Cut Curaleaf’s Target Price after Its Q4 Earnings

    Since Curaleaf reported its fourth-quarter earnings on March 24, Alliance Global Partners and Canaccord Genuity have lowered their target prices.

    By Rajiv Nanjapla
  • uploads///arizona cannabis legalization
    Cannabis

    Arizona Continues Marijuana Legalization Plans in 2020

    Marijuana activists in Arizona started the “Smart & Safe Arizona Initiative” as a ballot measure for 2020. The group gathered enough signatures.

    By Sushree Mohanty
  • uploads///cannabis stocks future
    Cannabis

    3 Cannabis Stocks Investors Should Watch as Markets Rebound

    As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.

    By Rajiv Nanjapla
  • uploads///marijuana essential
    Cannabis

    COVID-19 Pandemic Made Marijuana an Essential Item

    Amid the coronavirus pandemic, marijuana has become an essential item in many US states. As a result, there was a surge in cannabis demand.

    By Sushree Mohanty
  • uploads///curaleaf earnings results
    Cannabis

    Curaleaf Reports Impressive Q4 Earnings Results

    On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.

    By Rajiv Nanjapla
  • uploads///charlottes web earnings
    Cannabis

    Charlotte’s Web Stock Rose after Its Q4 Earnings

    Today, Charlotte’s Web Holdings (TSE:CWEB)(OTCMKTS:CWBHF) reported its fourth-quarter earnings. For the quarter, the company reported revenues of $22.8 million.

    By Rajiv Nanjapla
  • uploads///curaleaf beat expectations
    Cannabis

    Will Curaleaf Beat Analysts’ Expectations in Q4?

    Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.

    By Rajiv Nanjapla
  • uploads///cannabis fda approval
    Cannabis

    Cannabis Industry Awaits FDA’s Approval for CBD Products

    The FDA doesn’t allow CBD products to be used as a food derivative. The agency has been hesitant about how some cannabis companies market CBD products.

    By Sushree Mohanty
  • uploads///CWEB_
    Cannabis

    What to Expect from Charlotte’s Web’s Q4 Earnings

    Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating

    On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.

    By Rajiv Nanjapla
  • uploads///supreme cannabis analysts hold rating
    Cannabis

    What Do Analysts Recommend for Supreme Cannabis?

    Wall Street favors a “hold” rating for Supreme Cannabis. Four analysts recommend a ‘hold,’ three recommend a ‘buy,’ and one recommends a ‘sell.’

    By Rajiv Nanjapla
  • uploads///Green Growth
    Cannabis

    Charlotte’s Web Reports Improved Yield and CBD Potency

    On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.

    By Rajiv Nanjapla
  • uploads///Green Growth
    Cannabis

    What Do Analysts Recommend for Green Growth Brands?

    After Green Growth Brands reported its earnings, Eight Capital downgraded the stock from “buy” to “sell.” Currently, three analysts follow the company.

    By Rajiv Nanjapla
  • uploads///curaleaf bluekudu
    Cannabis

    How Will Curaleaf Benefit from Acquiring BlueKudu?

    On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.

    By Rajiv Nanjapla
  • uploads///gw pharmaceuticals target price cut
    Cannabis

    Analysts Cut GW Pharmaceuticals’s Target Price after Q4 Earnings

    On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings. The company reported revenue of $109.1 million, which beat analysts’ expectations.

    By Rajiv Nanjapla
  • uploads///IIPR
    Cannabis

    What Can You Expect from IIPR’s Q4 Earnings?

    IIPR will report its results for the fourth quarter of 2019 today after the market closes. Analysts expect the company to post revenue and EPS growth.

    By Rajiv Nanjapla
  • uploads///GWPH_
    Cannabis

    Analyzing GW Pharmaceuticals’ Q4 Earnings and Outlook

    On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings after the market closed. For the quarter, the company reported revenue of $109.1 million.

    By Rajiv Nanjapla
  • uploads///cannabis_
    Cannabis

    Green Growth Brands Reported Mixed Q2 Performance

    On Monday, Green Growth Brands reported its earnings results for the second quarter of fiscal 2020. The company reported revenues of $21.1 million.

    By Rajiv Nanjapla
  • uploads///green growth brands upcoming earnings
    Cannabis

    What to Expect from Green Growth Brands’ Q2 Earnings?

    Green Growth Brands will likely report its results for the second quarter of fiscal 2020 on February 24. Analysts expect the company’s revenue to rise sequentially.

    By Rajiv Nanjapla
  • uploads///Trump
    Cannabis

    Trump Denies Protection to State Medical Marijuana Programs

    President Trump introduced a proposal to end an existing policy introduced by Congress. The proposal will be part of the fiscal 2021 budget plan.

    By Sushree Mohanty
  • uploads///curaleaf__
    Cannabis

    Beacon Securities Is Still Bullish on Curaleaf

    After Curaleaf completed the acquisition of the Select brand, Russell Stanley of Beacon Securities reiterated his “buy” rating.

    By Rajiv Nanjapla
  • uploads///iipr and gti
    Cannabis

    IIPR Enters a Long-Term Agreement with GTI

    Yesterday, IIPR announced that it bought a licensed cannabis processing facility in Toledo, Ohio, from Green Thumb Industries for $2.9 million.

    By Rajiv Nanjapla
  • uploads///CL_
    Cannabis

    Cresco Labs Stock Rose after Securing $100 Million Loan

    On Thursday, Cresco Labs announced that it signed an agreement for a senior secured term loan for an initial aggregate principal amount of $100 million.

    By Rajiv Nanjapla
  • uploads///CL_
    Cannabis

    Is Cresco Labs a Good Bet in January?

    Analysts expect Cresco Labs to report revenues of $45.3 million in the fourth quarter to take the total revenue for 2019 to $131.9 million.

    By Rajiv Nanjapla
  • uploads///curaleaf__
    Cannabis

    Why Beacon Securities Is Bullish on Curaleaf

    On Monday, Russell Stanley of Beacon Securities reiterated his “buy” rating for Curaleaf Holdings. He gave a target price of 25 Canadian dollars.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Is Charlotte’s Web Still a Good Buy?

    Although 2019 was tough for Charlotte’s Web Holdings, it has made a significant recovery this year. The stock has increased by 14.8% YTD as of Monday.

    By Rajiv Nanjapla
  • uploads///curaleaf
    Cannabis

    Can Curaleaf Maintain Its Upward Momentum?

    Acquisitions could boost Curaleaf’s production and retail footprint significantly. With the EBITDA expected to rise over the next two years, there’s significant upside.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Does 2020 Look Bright for Cannabis in Florida?

    There was hope that cannabis legalization would see daylight in Florida in 2020. However, the state faces some hurdles.

    By Sushree Mohanty
  • uploads///KushCo_
    Cannabis

    What Do Analysts Recommend for KushCo Holdings?

    KushCo Holdings reported its Q1 earnings on January 8. KushCo reported revenue of $34.96 million, below analysts’ forecast of $41.5 million.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Stifel Gets Bullish on the Cannabis Sector in 2020

    According to a report by Barron’s on January 7, Stifel analysts expect a rebound in the cannabis sector in the first half of 2020.

    By Margaret Patrick
  • uploads///OGI_pic
    Cannabis

    OrganiGram’s First-Quarter Earnings: What to Expect

    Yesterday, OrganiGram stock was trading at 2.68 Canadian dollars, 23.4% lower than when the company reported its fourth-quarter earnings on November 25.

    By Rajiv Nanjapla
  • uploads///can_
    Cannabis

    Cannabis Sector Marks Third Straight Day of Decline

    The downward momentum in cannabis stocks has continued today, marking the third straight day of decline for the cannabis sector.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    ‘Make It Legal Florida’ Cannabis Campaign’s Next Step

    Florida’s “Make It Legal Florida” measure could push other states to look at cannabis legalization. However, President Trump doesn’t seem supportive.

    By Sushree Mohanty
  • uploads///Jan_
    Cannabis

    Why Cannabis Stocks Were Trading Lower Today

    On the back of the weakness in the broader equity market, the cannabis sector traded in the red today. At 1:28 PM ET, the S&P 500 Index was down by 0.4%.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Illinois Wakes Up to Legalized Recreational Cannabis

    On June 25, Illinois governor J.B. Pritzker signed a bill approving marijuana use for everyone over 21 years old. The law became effective on January 1.

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.